25 Nov

BLOOMBERG _ New Zealand's COVID-19 response rated best in the world

New Zealand is the best place in the world to be in the coronavirus era, according to the new Bloomberg Covid resilience ranking.

From Bloomberg: 

"New Zealand tops the Ranking as of Nov. 23 thanks to decisive, swift action. The small island nation locked down on March 26 before a single Covid-related death had occurred, shutting its borders despite the economy’s heavy reliance on tourism. Early on, Prime Minister Jacinda Ardern’s government said it would target “elimination” of the virus, pouring resources into testing, contact tracing and a centralized quarantine strategy to snuff out local transmission. Having largely achieved it, New Zealanders are basically living in a world without Covid. The nation has seen just a handful of infections in the community in recent months, and live music and large-scale social events are back on. Though its tourism industries are suffering, New Zealand is also well-positioned for a vaccine with two supply deals in place, including one for the shot developed by Pfizer Inc. and Germany’s BioNTech SE"

Link: https://www.bloomberg.com/grap...

Other News

The Benefits of Rapid Start Up and How to Achieve It

Time is often always a factor in the development of new therapies, especially for conditions with unmet medical needs or during global health emergencies like we saw with the pandemic.

Read more
PharmaSols CRO Dedicated Study Start-Up Team – Taking Trial Sites From Selection to Initiation Faster

Meet Jorrit Sipkema – Director Study Start-up at PharmaSols CRO, a HiRO company. Jorrit has worked over 20 years in clinical research in AsiaPac and Europe for Pharmaceutical companies, CRO's and Central Laboratories. His experience includes clinical operations, project management and quality assurance both at management and operations levels.

Read more
Clinical Trials in ANZ: Harnessing Population Diversity for Recruitment

Recruitment and retention of trial participants can often be a critical bottleneck in clinical research. It is widely accepted that almost half of all delays in clinical trials are a result of problems with patient recruitment and retention. When it comes to the success of clinical trials, patient recruitment and retention plays a pivotal role.

Read more